RECRO PHARMA INC shareholders Q3 2023

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

RECRO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Renaissance Technologies 836,017$3920.00%
Virtu Financial LLC 12,617$60.00%
DIMENSION CAPITAL MANAGEMENT LLC 10,591$4,9680.00%
Sandy Spring Bank 2,001$9390.00%
Tower Research Capital LLC (TRC) 22,058$10,3450.00%
Global Retirement Partners, LLC 15,100$6,7800.00%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 12,000$5,6280.00%
DHJJ Financial Advisors, Ltd. 5$30.00%
COMMONWEALTH EQUITY SERVICES, LLC 11,800$60.00%
ROYAL BANK OF CANADA 332$00.00%
VANGUARD GROUP INC 3,056,819$1,433,6480.00%
JANE STREET GROUP, LLC 23,577$11,0580.00%
UBS Group AG 8,151$3,8230.00%
BNP PARIBAS FINANCIAL MARKETS 257$1210.00%
BANK OF AMERICA CORP /DE/ 31,920$14,9700.00%
WELLS FARGO & COMPANY/MN 770$3610.00%
NORTHERN TRUST CORP 138,391$64,9060.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 790,167$370,6830.00%
STATE STREET CORP 126,858$59,4960.00%
External links

This page lists RECRO PHARMA INC's shareholders in Q3 2023. To view RECRO PHARMA INC's shareholder history, click here.